Press release
Global Erythropoietin Drugs Market (Products, Applications and Geography) : Industry Size, Share, And Groth to 2020
Intense Research
Erythropoietin is a glycoprotein hormone synthesized in the bone marrow that controls and regulates the mechanism of erythropoiesis (production of red blood cells). These erythropoietin (EPO) drugs are used for treatment of chemotherapy-induced anemia; anemia is a common side-effect occurring due to chemotherapy of End Stage Renal Diseases (ESRD), cancer and HIV. Improved recombinant DNA technology has led to development of synthetic forms of erythropoietin such as epoetin alfa, epoetin beta, darbepoetin alfa, epoetin omega, and epoetin delta among the others. The global EPO drugs market is thus driven by increasing number of patients suffering from anemic condition induced due to cancer, HIV and ESRD treatment; favorable reimbursements and increasing commercialization of EPO biosimilars. The global EPO drugs market would reach $11.9 billion by 2020, registering CAGR of 9.7% during 2014-2020.
Read Sample Report@http://goo.gl/NfzorK
Amongst all synthetic erythropoietin products, Epoetin alfa and its advance version, Darbepoetin alfa, are the most popular drugs. Epoetin alfa and Darbepoetin alfa collectively accounted for ~80% of total EPO drugs market revenue. Amgen Inc. was first company to innovate Epoetin alfa and Darbepoetin alfa that are branded/patented as Epogen and Aranesp respectively. However, expiration of Amgen’s patent for Epogen has aided manufacturers of biosimilars to enter the EPO drugs market. Availability of numerous biosimilars has rendered low-cost option to the patients, therefore increased adoption rates for EPO drugs particularly in the developing regions.
Based on the applications, the global EPO drugs market is segmented into anemia associated with End Stage Renal Diseases (ESRD), cancer chemotherapy and, antiretroviral treatment (ART). Current research is focused toward expanding the applications of EPO drugs in other disease conditions such as neural diseases and wound healing.
Global EPO drugs market is segmented based on geography into North America, Europe, Asia Pacific and LAMEA. Europe is the leading geographical market owing to favorable reimbursement policies and less stringent and speedy regulatory approvals for EPO drugs.
Key companies profiled in the report are, Amgen Inc., Johnson & Johnson, Hospira Inc., Roche, LG Life Sciences Ltd., Biocon, Intas Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., and Celltrion, Inc.
KEY BENEFITS
An in-depth analysis of current research and clinical developments within EPO drugs market is provided with key market dynamic factors that helps in understanding the behavior of market
The report provides the quantitative analysis of the current market and estimations through 2013-2020 that assists in identifying the prevailing market opportunities to capitalize on
Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework
Comprehensive analysis of all geographic regions are provided that helps in determining the prevailing opportunities in these geographies
Key market players within the EPO drugs market are profiled in the report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of global EPO drugs market
MARKET SEGMENTATION
The global EPO drugs market is segmented based on products, applications and geography.
MARKET BY PRODUCT TYPES
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
MARKET BY APPLICATIONS
Anemia (Cancer and HIV treatment)
Kidney Disorders (ESRD and Dialysis)
Others (Neural Disease and Wound healing)
MARKET BY GEOGRAPHY
North America
Europe
Asia-Pacific
LAMEA
About Us
Intense Research is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations.
Contact Us
Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
United States
Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 1-855-465-4651
Email: admin@intenseresearch.com
Web: http://www.intenseresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Erythropoietin Drugs Market (Products, Applications and Geography) : Industry Size, Share, And Groth to 2020 here
News-ID: 326772 • Views: …
More Releases from Intense Research
Global White Box Servers Market Manufacturing Base And Competitors Quanta, Wistr …
A white box server refers to customized servers that are either home built, or built by white box suppliers called ODMs (Original Design Manufacturers) such as Supermicro. The term white box simply means that the equipment is unbranded or generic. All parts are purchased separately which helps cut costs as well as provides hobbyists and data center professionals alike more customization to better fit their needs. The ease of customization…
Managed Mobility Services Market Future Trends 2020 - At&T, Fujitsu, IBM, Wipro, …
The research report "Managed Mobility Services Market: Global and Regional Analysis 2019 - 2024" discover accurate information about the long run prospects of this Managed Mobility Services market, which can help industry players to understand the flow of the market throughout the period 2019-2024. The global Managed Mobility Services market has defined the market scenario in an orderly way, emphasizing the industrial development, prominent players engaged from the current Managed…
Global Signature Verification Market Professional Survey 2020 - Biometric Signat …
The research report "Signature Verification Market: Global and Regional Analysis 2019 - 2024" discover accurate information about the long run prospects of this Signature Verification market, which can help industry players to understand the flow of the market throughout the period 2019-2024. The global Signature Verification market has defined the market scenario in an orderly way, emphasizing the industrial development, prominent players engaged from the current Signature Verification market, chapter…
Global Scientific and Technical Publication Market 2020 : Informa, John Wiley & …
The research report "Scientific and Technical Publication Market: Global and Regional Analysis 2019 - 2024" discover accurate information about the long run prospects of this Scientific and Technical Publication market, which can help industry players to understand the flow of the market throughout the period 2019-2024. The global Scientific and Technical Publication market has defined the market scenario in an orderly way, emphasizing the industrial development, prominent players engaged from…
More Releases for EPO
Global EPO Biomarkers Market Share: Trends, Key Players, Industry Analysis Repor …
The global EPO Biomarkers market is anticipated to grow at a modest CAGR of around 5.3% during the forecast period (2021-2027). EPO is produced by the kidneys and is a factor responsible for regulating red blood cell (RBC) production in mammals. Some of the EPO biomarkers available in the market are epoetin alfa, epoetin beta, epoetin zeta, epoetin theta, recombinant human erythropoietin, and darbepoetin alfa. Among these, the erythropoietin alfa…
EPO biomarkers Market Trends 2018 | Segmentation, Outlook, Industry Report to 20 …
Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers Market are used to increase the growth of red blood cells in the body by stimulating the bone marrow. Some of the EPO biomarkers available in the market are epoetin alfa, epoetin beta, epoetin zeta, epoetin theta, recombinant human erythropoietin, and darbepoetin alfa. Erythropoietin alfa is used to treat anemia and cancer…
EPO Biomarkers Market : Industry Research, Study, Growth Analysis Report 2019 & …
Researchmoz added Most up-to-date research on “Global EPO Biomarkers Market Size, Status and Forecast 2019-2025” to its huge collection of research reports.
The EPO Biomarkers market report [6 Year Forecast 2019-2025] focuses on Major Leading Industry Players, providing info like company profiles, product type, application and regions, production capacity, ex-factory price, gross margin, revenue, market share and speak to info. Upstream raw materials and instrumentation and downstream demand analysis is…
Global EPO Biomarkers Market Research and Forecast 2018-2023
Global EPO biomarkers market size, market intelligence, market trends, research and analysis report by biomarker (erythropoietin alfa, beta, zeta, theta, recombinant human erythropoietin, darbepoetin alfa) by applications (end-stage renal disorder, cancers, rheumatoid arthritis, aids, myelodysplastic syndrome, neurology, hematology) forecast 2018-2023
According to the OMR analysis, the global EPO biomarkers Market is expected to grow impressively during 2018-2023. The global EPO biomarkers market is segmented on the basis of biomarker type, applications,…
EPO Biosimilars - The Future of Erythropoietin Market
ReportsWorldwide has announced the addition of a new report title EPO Biosimilars - The Future of Erythropoietin Market to its growing collection of premium market research reports.
Erythropoietin is a hormone produced by healthy kidneys. This hormone prompts the bone marrow to make the red blood cells, which then carry oxygen throughout the body. Erythropoietin is used to treat anemia resulting from kidney failure or cancer treatment. It is considered to…
Global Erythropoietin (EPO) Market - Johnson & Johnson, Roche, Kyowa Hakko Kirin …
Erythropoietin market, also known as EPO, hematopoietin, or hemopoietin, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine (protein signaling molecule) for erythrocyte (red blood cell) precursors in the bone marrow. Human EPO has a molecular weight of 34 kDa.
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in…
